Chemed CEO sells shares after option exercise

Chemed Corp president and CEO Kevin J. McNamara reported an option exercise and related share dispositions.

Accepted by SEC EDGAR 08/04/2026 - 09:24 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Chemed Corp president and CEO Kevin J. McNamara reported an option exercise and related share dispositions. He exercised stock options for 2,001 shares at $445.35 and sold 2,000 shares of capital stock at a weighted average $539.51. An additional 19,802 shares were withheld to pay the option purchase price and related tax obligations. After the derivative transaction, he directly held 264,158 stock options.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 4 txns

Insider MCNAMARA KEVIN J

Role president and CEO

Sold 2,000 shs ($1.08M)

Approx. gross sale proceeds $1.08M

Approx. exercise cost $891K

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy with tandem tax withholding) F3	2,001	$445.35	$891K
Sale	Capital Stock F2	2,000	$539.51	$1.08M
Exercise	Capital Stock	2,001	$445.35	$891K
Tax Withholding	Capital Stock F1	19,802	$529.22	$10.48M

Holdings After Transaction: Stock Option (right to buy with tandem tax withholding) — 264,158 options (Direct); Capital Stock — 70,418 shares (Direct)

Footnotes (3)

1. F1. Payment of purchase price and tax obligation on stock option exercise.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.59 to $543.50. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4.
3. F3. Vesting in three equal annual installments commencing 10/28/2022.

Key Figures

Options exercised: 2,001 shares Exercise price: $445.35 per share Shares sold: 2,000 shares +3 more

6 metrics

Options exercised 2,001 shares Stock options exercised into capital stock at $445.35 per share

Exercise price $445.35 per share Strike price for 2,001-share stock option exercise

Shares sold 2,000 shares Capital stock sale on 2026-08-03 at weighted average $539.51

Sale price range $533.59–$543.50 Price range of multiple sale transactions included in weighted average

Tax and purchase withholding 19,802 shares Shares delivered/withheld to pay option purchase price and related tax obligation

Options held after transaction 264,158 options Stock options directly held following the reported derivative exercise

Key Terms

Stock Option (right to buy with tandem tax withholding), weighted average price, tax-withholding disposition, Payment of tax liability by delivering or withholding securities

4 terms

Stock Option (right to buy with tandem tax withholding) financial

"Security titled "Stock Option (right to buy with tandem tax withholding)""

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Payment of tax liability by delivering or withholding securities financial

"transaction_code_description": "Payment of tax liability by delivering or withholding securities""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did CHE CEO Kevin McNamara report in this Form 4?

Kevin McNamara reported exercising stock options for 2,001 shares at $445.35, selling 2,000 shares of Chemed Corp capital stock, and having 19,802 shares withheld to cover the purchase price and taxes related to the option exercise.

How many CHE shares did Kevin McNamara sell, and at what price?

He sold 2,000 shares of Chemed Corp (CHE) capital stock at a weighted average price of $539.51. The sale occurred in multiple transactions within a price range from $533.59 to $543.50, as disclosed in the transaction footnote.

What portion of Kevin McNamara’s CHE shares were withheld for taxes?

The Form 4 shows 19,802 shares of Chemed Corp capital stock were disposed of to pay the option purchase price and tax obligation on the stock option exercise, meaning the issuer withheld or received these shares rather than them being sold on the open market.

What option exercise did the CHE CEO report and at what strike price?

McNamara exercised stock options covering 2,001 underlying shares of Chemed Corp capital stock at an exercise price of $445.35 per share. The options are described as a Stock Option (right to buy with tandem tax withholding) and were part of a previously granted award.

How many CHE stock options does Kevin McNamara hold after these transactions?

Following the reported derivative transaction, McNamara directly held 264,158 stock options linked to Chemed Corp capital stock. This figure reflects his remaining option position in the specific option series reported, not necessarily all equity awards he may hold.

What does the vesting footnote say about the CHE CEO’s stock options?

A footnote explains that the reported stock option award vests in three equal annual installments commencing 10/28/2022. This schedule describes how the grant becomes exercisable over time, aligning with typical multi-year executive equity compensation structures at public companies like Chemed Corp (CHE).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCNAMARA KEVIN J

(Last) (First) (Middle)

2600 CHEMED CENTER

255 EAST 5TH STREET

(Street)

CINCINNATI OHIO 45202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CHEMED CORP [ CHE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	president and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Capital Stock	07/31/2026		M		2,001	A	$445.35	92,220	D
Capital Stock	07/31/2026		F(1)		19,802	D	$529.22	72,418	D
Capital Stock	08/03/2026		S		2,000	D	$539.51(2)	70,418	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy with tandem tax withholding)	$445.35	08/03/2026		M			2,001	(3)	10/28/2026	Capital Stock	2,001	$445.35	264,158	D

Explanation of Responses:

1. Payment of purchase price and tax obligation on stock option exercise.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.59 to $543.50. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4.

3. Vesting in three equal annual installments commencing 10/28/2022.

	Kevin J. McNamara	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)